» Flotte named associate editor of Human Gene Therapy
  Print Friendly Print

Flotte named associate editor of Human Gene Therapy Human Gene therapy

By Ellie Castano
UMass Medical School Communications 		August 15, 2011 

flotte, terry
Terence R. Flotte, MD 
Terence R. Flotte, MD, executive deputy chancellor and provost, dean of the School of Medicine, the Celia and Isaac Haidak Professor in Medicine and professor of pediatrics, has been named an associate editor of the journal Human Gene Therapy, which publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Improvements in vector development, delivery systems and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, are covered. Founded more than 30 years ago, it is the official journal of the European Society for Gene and Cell Therapy as well as other country-specific gene therapy societies, and has a 2011 Thomson/ISI impact factor of 4.829, reflecting its increasing stature in the field.

“It is a great honor to be named to the worldwide team of scientists responsible for the evolution and growth of the journal Human Gene Therapy,” said Dr. Flotte. “Editor-in-Chief James Wilson has done a remarkable job in building support for the journal. I look forward to supporting him in that role, and broadening the scope and relevance of the journal. One example of that will be a new perspective piece on the role of gene and all therapies in the health care reform era.”